Cyclotek Manufacturing Partnership for Kidney Cancer Imaging
Filed with ASX ·
6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Strategic Collaboration Agreement with GenesisCare
- Telix completes acquisition of Atlab Pharma
- TLX receives ethics approval to commence Glioblastoma Study
- Half Yearly Report and Accounts
- Telix files Ph III trial for Kidney Cancer Imaging in Europe
Later from Telix Pharmaceuticals
- Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
- Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial
- Appendix 4C - September Quarter
- Telix Acquires Advanced Nuclear Medicine Ingredients SA
- ANMI Transaction - Market Briefing
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals